Evidence map›Paper›PMID 22549052›Full record

ArticleAnnals of clinical microbiology and antimicrobials2012

Bioassay-guided discovery of antibacterial agents: in vitro screening of Peperomia vulcanica, Peperomia fernandopoioana and Scleria striatinux.

James A Mbah, Moses N Ngemenya, Ashime Louis Abawah, Smith B Babiaka, Lina N Nubed, Kennedy D Nyongbela, Njimoh Dieudonne Lemuh, Simon M N Efange

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Antimicrobial Activities and Mode of Flavonoid Actions.Antibiotics (Basel, Switzerland) · 2023
    Article
  4. In Vitro Antibacterial Potential against Multidrug-ResistantEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  5. The Extremophilic Actinobacteria: From Microbes to Medicine.Antibiotics (Basel, Switzerland) · 2021
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

James A MbahDepartment of Chemistry, Faculty of Science, University of Buea, P.O. Box 63 Buea, Southwest Region, Cameroon.
Moses N Ngemenya
Ashime Louis Abawah
Smith B Babiaka
Lina N Nubed
Kennedy D Nyongbela
Njimoh Dieudonne Lemuh
Simon M N Efange
University of Buea · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global burden of bacterial infections is high and has been further aggravated by increasing resistance to antibiotics. In the search for novel antibacterials, three medicinal plants: Peperomia vulcanica, Peperomia fernandopoioana (Piperaceae) and Scleria striatinux (Cyperaceae), were investigated for antibacterial activity and toxicity.

methodsCrude extracts of these plants were tested by the disc diffusion method against six bacterial test organisms followed by bio-assay guided fractionation, isolation and testing of pure compounds. The minimum inhibitory (MIC) and minimum bactericidal (MBC) concentrations were measured by the microdilution method. The acute toxicity of the active extracts and cytotoxicity of the active compound were performed in mice and mammalian cells, respectively.

resultsThe diameter of the zones of inhibition (DZI) of the extracts ranged from 7-13 mm on Escherichia coli and Staphylococcus aureus of which the methylene chloride:methanol [1:1] extract of Scleria striatinux recorded the highest activity (DZI = 13 mm). Twenty-nine pure compounds were screened and one, Okundoperoxide, isolated from S. striatinux, recorded a DZI ranging from 10-19 mm on S. aureus. The MICs and MBCs indicated that the Peperomias had broad-spectrum bacteriostatic activity. Toxicity tests showed that Okundoperoxide may have a low risk of toxicity with an LC50 of 46.88 μg/mL.

conclusionsThe antibacterial activity of these plants supports their use in traditional medicine. The pure compound, Okundoperoxide, may yield new antibacterial lead compounds following medicinal chemistry exploration.

Indexed as

AnimalsAnti-Bacterial AgentsBiological AssayCell LineCyperaceaeDisk Diffusion Antimicrobial TestsDrug DiscoveryDrug Resistance, Multiple, BacterialFemaleGram-Negative BacteriaGram-Positive BacteriaLethal Dose 50MaleMethanolMethylene ChlorideMiceAnti-Bacterial AgentsMethanolMethylene ChlorideokundoperoxidePlant ExtractsSesquiterpenes

Identifiers

PMID22549052
PMCPMC3403929
OpenAlexW2114790497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.